LPL Financial »

Protalix Biotherapeutics shares owned by LPL Financial

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by LPL Financial from 13F filings

Historical chart of LPL Financial investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by LPL Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by LPL Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $23k 10k 2.22

More positions owned by LPL Financial

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr Series Trust Portfolio S&p500 (SPLG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Core Msci Emkt (IEMG)
Vanguard Index Fds Growth Etf (VUG)

View all positions for LPL Financial

Top funds holding Protalix Biotherapeutics

BlackRock
Opaleye Management
Renaissance Technologies
Northern Trust
Geode Capital Management
Stratos Wealth Partners
State Street Corporation
Vanguard Group
Morgan Stanley
Connor, Clark & Lunn Investment Management
UBS Group
Bridgeway Capital Management
Diametric Capital
Charles Schwab Investment Management
Commonwealth Equity Services

View all funds holding Protalix Biotherapeutics